Covid-19 vaccine delays: AstraZeneca pulls out of meeting with EU.

AstraZeneca has pulled out from a meeting with the European Union scheduled for Wednesday to discuss COVID-19 vaccine supplies, an EU official said. The official added that the EU keeps asking the company to provide further explanations about its announcement to cut vaccine deliveries to the EU in the first quarter.

Earlier, AstraZeneca chief executive Pascal Soriot has attributed its vaccine delivery shortfall in Europe to production teething problems – and the EU’s delay in signing a contract with the Swedish pharmaceutical firm.

Mr Soriot said he understands frustration with his company but hit back at claims that its cut in vaccine dose delivery to the EU was allowing it prioritise the UK and other customers.

The European Commission has described delays in vaccine delivery – 40 per cent below targets in March – as “not acceptable”, with some EU member states threatening legal action.

Mr Soriot said such threats are baseless, claiming his company had always only promised its “best effort” to supply the EU in parallel with the UK.

The company’s problems at EU production plants in the Netherlands and Belgium, he said, are due to a lower output in some production tanks containing vaccine culture.

“We had similar teething problems in the UK but the contract with the British was signed three months before that with Brussels and we had three months more time to sort out issues,” he told Germany’s Die Welt daily and Italy’s La Repubblica.

The AstraZeneca chief executive said his company was not profiteering or price-gouging, as it had undertaken to produce the vaccine in conjunction with Oxford University on a non-profit basis. Nor would the French-born manager tolerate any preferred treatment for non-EU customers.

“I’m a European, our chairman is too, as is our finance chief,” he said.

As for German media claims that the vaccine had an efficacy of merely 8 percent in the elderly population, Mr Soriot said he had “no idea” where such claims came from.

“How can one assume that testing bodies around the world would grant a licence to a substance with only eight per cent efficacy,” he asked.

The company’s vaccine is already being used in the UK, with the EU’s medical approval likely to follow next week.

Pending approval the company will deliver three million doses to the EU, increasing each week until a ceiling of 17 million per seven days is reached. The doses will be divided and distributed around the EU based on population size.

Calling into doubt the vaccine’s efficacy, he warned, was a gift to anti-vaccine movements gathering strength around the continent.

“Whoever has something to say about security or efficacy should do it in scientific circles, it’s disgraceful to do this for political means because it reduces the trust in vaccination,” he said.

Among the concerns raised about the vaccine’s efficacy are how only eight percent of the subjects in the Oxford vaccine trials were between 56 and 69 years of age, and only three to four percent were over 70 years of age.

Mr Soriot said that ethical reasons were behind the low numbers of older test subjects.

“Oxford ... didn’t want to test older people until they had enough data from the 18-55 year-old group,” he said. “But we have robust data that prove a strong antibody production against the virus among older people.”

He said it was too soon to tell whether the company’s vaccine would protect against virus mutations already in circulation.

Politicians across Europe have backed calls to introduce export permits for vaccines, amid concerns that AstraZeneca’s EU-based factories was prioritising production for other areas in the world at the expense of Europeans.

Mr Soriot said such talk of export restrictions was “exactly the opposite” of undertakings given by the European Commission in recent months. Such proposals for its EU production facilities, he added, risked undermining the company’s international delivery chain.

The French executive suggested a lack of global readiness for pandemics, and the resulting lapse into nationalist instincts, was the main challenge in tackling the pandemic.

Vaccine development in record time “could have been a Fourth of July, Independence Day kind of a moment but it unfortunately wasn’t because there was a little bit of ‘me first’ behaviour,” he told a virtual panel of the World Economic Forum.

As well as a battle with Brussels, the Swedish company is being sued by a pension fund on behalf of its investors, claiming they suffered losses because of flaws in the company’s testing of its coronavirus vaccine.

The Irish Times

The Irish Times online. Latest news including sport, analysis, business, weather and more from the definitive brand of quality news in Ireland.

https://www.irishtimes.com/

Related news
John Rich reveals his dream career if he wasn't a country musician.

John Rich reveals his dream career if he wasn't a country musician.

Country music songwriter joins 'The Ingraham Angle' as this week's mystery guest. #FoxNews #Ingraham Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 24-hour all-encompassing news service d...

Sky News Breakfast: Myanmar's 'Tiananmen moment' and NHS pay row.

Sky News Breakfast: Myanmar's 'Tiananmen moment' and NHS pay row.

On your Sky News Breakfast menu: - A moment of courage in Myanmar's deadly demonstrations as a nun filmed pleading to protect protesters says she was ready to die - NHS trusts accuse the government of snatching away a promised larger pay rise for ...

Despite drop in unemployment, Biden still pushing COVID relief bill.

Despite drop in unemployment, Biden still pushing COVID relief bill.

Republicans using jobs report as ammunition to fight against stimulus package; FOX News' Peter Doocy on 'Special Report.' #FoxNews Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 24-hour a...

Live: Prince Philip transferred back to a private hospital after heart surgery.

Live: Prince Philip transferred back to a private hospital after heart surgery.

Prince Philip has been transferred back to a private hospital after successfully undergoing a procedure to treat a heart condition, Buckingham Palace said on Friday (March 5). Philip, the Duke of Edinburgh who has been hospitalised for more than t...

Live: Democrats advance Biden's $1.9 trillion COVID-19 bill

Live: Democrats advance Biden's $1.9 trillion COVID-19 bill

Democrats forged ahead with President Joe Biden’s $1.9trn coronavirus relief plan early on Saturday, holding back Republican attempts to modify the package. With Republicans united in opposition, Democrats who narrowly control the chamber must kee...

Josh Hawley claims big corporations are getting rich employing illegal labor.

Josh Hawley claims big corporations are getting rich employing illegal labor.

Missouri Republican senator discusses his plan to bring jobs back to working people on 'FOX News Primetime.' #FoxNews #FoxNewsPrimetime Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 24-h...